Given the important role of the TGF‐β1 signaling pathway in the process of inflammation and the formation of liver fibrosis, it is possible that the signaling pathway could be a therapeutic target in reducing the effects of liver fibrosis [83]. This evidence concerns the gene TGFB1 and Hepatic fibrosis.